Profil bibliographique

T. Shirafuji

Informations fournies par OpenAlex. Research Africa ne déduit ni nationalité, ni poste, ni coordonnées personnelles.

27Publications signalées

484Citations signalées

2Affiliations récentes

Les institutions déclarées

Les domaines associés

Cosmology and Gravitation TheoriesRelativity and Gravitational TheoryBlack Holes and Theoretical PhysicsBladder and Urothelial Cancer TreatmentsProstate Cancer Treatment and Research

Les publications récentes

Accès ouvert 2026 dataset OpenAlex

Reproducibility package: estimand sensitivity of event-free survival with perioperative enfortumab vedotin–pembrolizumab in KEYNOTE-905 and KEYNOTE-B15

Satoshi Yamamoto, Manabu Kanasugi, T. Shirafuji, Hiroki Bamba et autres

jp (code pays fourni par la source)

0 citations Zenodo (CERN European Organization for Nuclear Research)

Accès ouvert 2026 dataset OpenAlex

Reproducibility package: estimand sensitivity of event-free survival with perioperative enfortumab vedotin–pembrolizumab in KEYNOTE-905 and KEYNOTE-B15

Satoshi Yamamoto, Manabu Kanasugi, T. Shirafuji, Hiroki Bamba et autres

jp (code pays fourni par la source)

0 citations Zenodo (CERN European Organization for Nuclear Research)

Accès ouvert 2026 review OpenAlex

Pretreatment factors informing treatment selection between perioperative enfortumab vedotin plus pembrolizumab and neoadjuvant gemcitabine-cisplatin in cisplatin-eligible, resectable muscle-invasive bladder cancer: protocol for a systematic review of comparative effect modification and treatment-related toxicity

Satoshi Yamamoto, Hiroki Bamba, Manabu Kanasugi, T. Shirafuji et autres

jp (code pays fourni par la source)

0 citations Zenodo (CERN European Organization for Nuclear Research)

Accès ouvert 2026 review OpenAlex

Pretreatment factors informing treatment selection between perioperative enfortumab vedotin plus pembrolizumab and neoadjuvant gemcitabine-cisplatin in cisplatin-eligible, resectable muscle-invasive bladder cancer: protocol for a systematic review of comparative effect modification and treatment-related toxicity

Satoshi Yamamoto, Hiroki Bamba, Manabu Kanasugi, T. Shirafuji et autres

jp (code pays fourni par la source)

0 citations Zenodo (CERN European Organization for Nuclear Research)

Accès ouvert 2026 review OpenAlex

Pretreatment factors informing treatment selection between perioperative enfortumab vedotin plus pembrolizumab and neoadjuvant gemcitabine-cisplatin in cisplatin-eligible, resectable muscle-invasive bladder cancer: protocol for a systematic review of comparative effect modification and treatment-related toxicity

Satoshi Yamamoto, Hiroki Bamba, Kazuyoshi Nakamura, T. Shirafuji et autres

jp (code pays fourni par la source)

0 citations Zenodo (CERN European Organization for Nuclear Research)

Accès ouvert 2026 review OpenAlex

Pretreatment factors informing treatment selection between perioperative enfortumab vedotin plus pembrolizumab and neoadjuvant gemcitabine-cisplatin in cisplatin-eligible, resectable muscle-invasive bladder cancer: protocol for a systematic review of comparative effect modification and treatment-related toxicity

Satoshi Yamamoto, Hiroki Bamba, Manabu Kanasugi, T. Shirafuji et autres

jp (code pays fourni par la source)

0 citations Zenodo (CERN European Organization for Nuclear Research)

2026 article OpenAlex

IP38-27 DISCORDANCE BETWEEN PSA LEVEL AND BONE-METASTATIC VOLUME IS ASSOCIATED WITH UNFAVORABLE PROGNOSIS IN PATIENTS WITH METASTATIC HORMONE-SENSITIVE PROSTATE CANCER

T. Shirafuji, Yasutaka Yamada, Kodai Sato, Takaaki Tamura et autres

0 citations The Journal of Urology

2026 article OpenAlex

Discordance between PSA level and bone metastatic volume is associated with unfavourable prognosis

T. Shirafuji, Yasutaka Yamada, Kodai Sato, Zhao Xue et autres

jp (code pays fourni par la source)

0 citations Institutional Repositories DataBase (IRDB)

2026 article OpenAlex

Prolonged Castration Prior to Docetaxel Reduces Febrile Neutropenia in Patients With Metastatic Hormone-sensitive Prostate Cancer Receiving Triple Therapy

Yasutaka Yamada, T. Shirafuji, Kodai Sato, TAKUYA TSUJINO et autres

jp (code pays fourni par la source)

0 citations Anticancer Research

2025 article OpenAlex

Discordance between PSA level and bone metastatic volume is associated with unfavourable prognosis

T. Shirafuji, Yasutaka Yamada, Kodai Sato, Xue Zhao et autres

jp (code pays fourni par la source)

0 citations British Journal of Urology

Accès ouvert 1999 article OpenAlex

Higher Derivative Gravity in Generalized Covariant Derivative Formalism

I. S. Sogami, Hajime Tanaka, T. Shirafuji

jp (code pays fourni par la source)

0 citations Progress of Theoretical Physics

Accès ouvert 1996 article OpenAlex

Energy of General Spherically Symmetric Solution in the Tetrad Theory of Gravitation

T. Shirafuji, G. G. L. Nashed, K. Hayashi

jp (code pays fourni par la source)

50 citations Progress of Theoretical Physics

Notice OpenAlex

BNTIC News n’est pas le producteur de ces données. Les publications sont interrogées à la demande dans Crossref, OpenAIRE, DOAJ, Europe PMC, HAL, DataCite, AfricArXiv, ROR et la Banque mondiale, sans clé d’accès. OpenAlex reste optionnel. Aucun service payant n’est nécessaire et aucune donnée externe n’est enregistrée en base. Consulter les sources et leurs limites.